Healthcare entity
regulation is the sole category represented across all 1 tracked stories. Lo Chung-mau is most often covered alongside Centre for Medical Products Regulation, which appears in 1 of these 1 story. Lo Chung-mau appears in 1 tracked Healthcare story from June 26, 2026.
Last mentioned: Jun 26, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Lo Chung-mau is most often covered alongside Centre for Medical Products Regulation, which appears in 1 of these 1 story. Lo Chung-mau appears in 1 tracked Healthcare story from June 26, 2026. The tracked stories average 3 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Lo Chung-mau. Shared-story counts are live from our verified record — not editorial picks.
Hong Kong’s upcoming Centre for Medical Products Regulation aims to speed patient access to innovative drugs by becoming a primary evaluator. The interim '1+' pathway has already approved 21 drugs, demonstrating the model’s potential to reshape the city’s healthcare landscape.
Source: Emily Hung (cn) · Emily Hung (hk)
Lo Chung-mau is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
